Bridger Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-99,795
Closed -$3.04M 29
2024
Q1
$3.04M Buy
99,795
+12,695
+15% +$425K 1.37% 20
2023
Q4
$3.11M Buy
+87,100
New +$3.24M 1.19% 21
2020
Q1
Sell
-261,524
Closed -$8.5M 37
2019
Q4
$8.5M Buy
+261,524
New +$7.44M 0.61% 33

Other funds holding ATRC

Bridger Management's ATRC Position: Q2 2024 in Review

Bridger Management sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 99,795 shares — an estimated $3.04M sold.

Bridger Management first reported a position in ATRC in Q4 2019 and held it in 3 quarters. The position peaked at $8.5M in Q4 2019. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Bridger Management reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Bridger Management sold 99,795 AtriCure shares in Q2 2024, an estimated $3.04M.
  • Bridger Management first reported a position in AtriCure in Q4 2019 and held it in 3 quarters.
  • Bridger Management's AtriCure position peaked at $8.5M in Q4 2019.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Bridger Management's 13F filing for Q2 2024, filed 14 Aug 2024.